This event is now closed, information is displayed here for information only.
The next ‘Frontiers of Oncology: Colorectal Cancer’ meeting will be announced in 2019
but you can pre-register HERE to be advised when the programme is released
Tuesday 5th February 2019
The Royal College of Physicians, London, UK

Chairs

 

Professor Daniel Hochhauser
Professor Daniel Hochhauser
Kathleen Ferrier Professor &
Co-Director CRUK UCL
Cancer Centre
Professor John Bridgewater
Professor of Medical Oncology,
Research Department of Oncology,
UCL Cancer Institute

08:00
Badge Collection & Coffee

09:30
Welcome / Setting the scene: The Chairs

SESSION 1: Diagnostics

09:35
New molecular diagnostics
Professor Marco Novelli
Consultant Histopathologist and Professor of Gastrointestinal Pathology, UCLH NHS Foundation Trust, London, UK

10:05
Genome sequencing in colorectal cancer
Professor Ian Tomlinson
Director of the Institute of Cancer and Genomic Sciences, The University of Birmingham, UK

10:35
Emerging therapies in GI cancer
Professor Simon Leedham
Associate Professor, Wellcome Trust Senior Research Fellow in Clinical Science, Wellcome Trust Centre for Human Genetics, University of Oxford

11:15
Coffee Break

11:40
Tracking treatment resistant cells in bowel cancers
Professor Trevor Graham
Professor of Cancer Evolution, Barts Cancer Institute, London, UK

12:10
Optimising diagnosis and treatment options for CRC patients
Dr Giulia Siravegna
Postdoctoral Research Fellow, Candiolo Cancer Institute, Torino, Italy

12:50
Targeting tumour angiogenesis in cancer treatment
Professor Kairbaan Hodivala-Dilke
Professor of Angiogenesis, Deputy Institute Director, Barts Cancer Institute, London, UK

13:20
Lunch

14:05
Promises and challenges in biomarker discovery for targeted therapy
Dr Nicola Valeri
Team Leader, The Gastrointestinal Cancer Biology and Genomics Team, The Centre for Molecular Pathology, The Institute of Cancer Research, London, UK

14:35
Liver metastasis from colorectal cancer
Professor John Bridgewater
Professor of Medical Oncology, Research Department of Oncology, UCL Cancer Institute, London, UK

SESSION 3: Immunotherapy

15:05
Immunotherapy in GI cancers
Professor Richard Wilson
Clinical Professor, Centre for Cancer Research and Cell Biology, Institute for Health Sciences, Queen’s University Belfast, Northern Ireland, UK

SESSION 4: EGFR

15:35
EGFR therapy in Right and Left colon cancer – biological differences and clinical trials
Professor Daniel Hochhauser
Co-Director of the Cancer Research UK-UCL Centre, Kathleen Ferrier Professor & Consultant Medical Oncologist at University College London, UK

15:55
Summary

16:00
Close


Costs
The meeting costs have been underwritten by sponsors from the Pharmaceutical Industry and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity. As support agreements are reached, disclosure of the supporters is listed here.

This meeting is organised by:

New UCL Logo2 800

ATL-new-logo-July-2015-800px

 

and endorsed and supported by:

TLO

TL


The Frontiers of Oncology 2019 meetings are supported by the Pharmaceutical Industry.
As support agreements are reached, disclosure of the supporters is listed here.